Scrying Biotech
Long only, biotech, micro-cap, small-cap

Sunshine Heart: An Elementary Question Reveals A Profound Problem

I'm a long-term investor and short-term trader of stocks. I don't buy or sell options, but were I too, I wouldn't hesitate to short Sunshine Heart (SSH) at this time. The reason for this is simple: trial enrollment numbers for 2013 in the pivotal phase 3 Counter-HF trial were abysmal.

I don't want to lose money or have funds tied up in a company whose trial completion date might extend outward like the Emerald City on the road to the Wizard of Oz.

If you want to find out how terrific of a device this is, I want you to read a series of articles by Robert Honeywell right here on Seeking Alpha that address its enormous market...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
Money back guarantee. Seeking Alpha PRO members receive a no-questions-asked refund for membership on months paid and not used. Details